bosentan anhydrous has been researched along with Hypertrophy in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (33.33) | 18.2507 |
| 2000's | 3 (50.00) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arzt, M; Blumberg, FC; Budweiser, S; Luchner, A; Pfeifer, M; Schroll, S; Sebah, D; Stoelcker, B | 1 |
| Scott, D; Shandas, R; Stenmark, KR; Tan, W; Tan, Y | 1 |
| Larivière, R; Li, JS; Schiffrin, EL | 1 |
| Li, JS; Schiffrin, EL; Schürch, W | 1 |
| Allen, TJ; Cao, Z; Cooper, ME; Cox, AJ; Gilbert, RE; Kelly, DJ; Rumble, JR; van Eeden, P | 1 |
| Belabbas, H; Herizi, A; Jover, B; Mimran, A | 1 |
6 other study(ies) available for bosentan anhydrous and Hypertrophy
| Article | Year |
|---|---|
Effects of selective and unselective endothelin-receptor antagonists on prostacyclin synthase gene expression in experimental pulmonary hypertension.
Topics: Animals; Bosentan; Cytochrome P-450 Enzyme System; Endothelin Receptor Antagonists; Gene Expression Regulation, Enzymologic; Heart Ventricles; Hemodynamics; Hypertension, Pulmonary; Hypertrophy; Immunohistochemistry; Intramolecular Oxidoreductases; Lung; Male; Organ Size; Phenylpropionates; Pulmonary Artery; Pyridazines; Rats; Rats, Wistar; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Sulfonamides | 2008 |
High pulsatility flow stimulates smooth muscle cell hypertrophy and contractile protein expression.
Topics: Actins; Animals; Bosentan; Cattle; Cells, Cultured; Coculture Techniques; Endothelial Cells; Hypertrophy; Mechanotransduction, Cellular; Myocytes, Smooth Muscle; Myosin Heavy Chains; Peptidyl-Dipeptidase A; Pulmonary Artery; Pulsatile Flow; Ramipril; Sulfonamides; Transforming Growth Factor beta1; Vascular Stiffness | 2013 |
Effect of a nonselective endothelin antagonist on vascular remodeling in deoxycorticosterone acetate-salt hypertensive rats. Evidence for a role of endothelin in vascular hypertrophy.
Topics: Acetylcholine; Animals; Arteries; Bosentan; Desoxycorticosterone; Endothelin Receptor Antagonists; Endothelins; Hypertension; Hypertrophy; Male; Rats; Rats, Sprague-Dawley; Renin; Sodium Chloride; Sulfonamides; Vasoconstriction | 1994 |
Renal and vascular effects of chronic endothelin receptor antagonism in malignant hypertensive rats.
Topics: Animals; Arteries; Blood Pressure; Bosentan; Desoxycorticosterone; Endothelin Receptor Antagonists; Endothelin-1; Hemodynamics; Hypertension, Malignant; Hypertrophy; Kidney; Organ Size; Rats; Rats, Inbred SHR; Renin; Sulfonamides | 1996 |
Endothelin receptor antagonism ameliorates mast cell infiltration, vascular hypertrophy, and epidermal growth factor expression in experimental diabetes.
Topics: Animals; Antihypertensive Agents; Blotting, Northern; Bosentan; Diabetes Mellitus, Experimental; Diabetic Angiopathies; Endothelin Receptor Antagonists; Endothelium, Vascular; Epidermal Growth Factor; Extracellular Matrix; Gene Expression; Hypertrophy; In Situ Hybridization; Male; Mast Cells; Mesenteric Arteries; Rats; Rats, Sprague-Dawley; RNA, Messenger; Sulfonamides | 2000 |
[Cardiac and vascular hypertrophy in hypertension due to angiotensin II. Effect of losartan and bosentan].
Topics: Analysis of Variance; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Blood Pressure; Body Weight; Bosentan; Cardiomegaly; Carotid Arteries; Endothelin Receptor Antagonists; Endothelins; Follow-Up Studies; Hypertension; Hypertrophy; Losartan; Male; Organ Size; Rats; Rats, Sprague-Dawley; Sulfonamides | 2000 |